17 results
424B3
NTBL
Notable Labs Ltd
5 Sep 23
Prospectus supplement
6:02pm
or toxic tort claims that may be asserted against Notable in connection with Notable’s, or its contractors, storage or disposal of biological, hazardous
S-4/A
l9eqzb0cc4w8u uoq
30 Jun 23
Registration of securities issued in business combination transactions (amended)
4:38pm
S-4/A
EX-10.20
su05ywuz8oz6hhmam
30 Jun 23
Registration of securities issued in business combination transactions (amended)
4:38pm
S-4
oi7eugx5ve8sot1a1
11 May 23
Registration of securities issued in business combination transactions
9:09am
6-K
EX-1.1
h3wdj 5z3
11 Feb 22
Current report (foreign)
5:29pm
6-K
EX-1.1
yq67p
12 Apr 21
Vascular Biogenics Ltd. Prices Public Offering of Ordinary Shares and Pre-Funded Warrants
9:10am
6-K
EX-99.1
da5ga2jifil7fvl
15 Jan 21
Ordinary Share Purchase Agreement
7:01am
6-K
EX-10.1
l7fh9xh1p btkbrvd3sd
12 May 20
Current report (foreign)
12:04pm
6-K
EX-10.1
ikrix8
11 May 20
VBL Therapeutics Announces $10.0 Million Registered Direct Offering
9:23am
6-K
EX-10.1
omo1nq2505bt6y
17 May 19
Current report (foreign)
5:20pm
6-K
EX-1.1
5hp0npqhn d9dvyp0b
27 Jun 18
VBL Therapeutics Announces $15.5 Million Registered Direct Offering Priced At-the-Market
9:29am
- Prev
- 1
- Next